This series “Mediastinoscopic Esophagectomy for Esophageal Cancer” is edited by Prof. Yutaka Tokairin from Toshima Hospital Tokyo Metropolitan Health and Hospitals Corporation, Tokyo, Japan.
Yutaka Tokairin, MD, PhD
Toshima Hospital Tokyo Metropolitan Health and Hospitals Corporation, 33-1 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan
Dr. Yutaka Tokairin M.D., Ph.D. graduated from Yamanashi Medical University in 1996. He graduated from the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University in 2006. He is currently working as a medical director of surgery in Toshima Hospital Tokyo Metropolitan Health and Hospitals Corporation.
Dr. Tokairin specializes in mediastinoscopic esophagectomy for esophageal cancer. He developed the method of mediastinoscopic esophagectomy using pneumomediastinum. In addition, he demonstrated the histological features of the thin membranous structure made of dense connective tissue around the esophagus.
Dr. Tokairin is a member of the international editorial board in Esophageal Surgery, and has performed many peer reviews. He has contributed to scientific journals and congresses and received many best presentation awards, including a Paper Award at the 11th Asia Pacific Congress of Endoscopic and Laparoscopic Surgery (ELSA2011) and an award for esophageal surgery from the Japanese Bronchoesophagological Society in 2016.
Series outline:
- Can Mediastinoscopic esophagectomy be a choice of curative surgery? - from the viewpoint of the short-term outcomes (Kazuhiko Mori)
- Can Mediastinoscopic esophagectomy be a choice of curative surgery? - from the viewpoint of the dissected mediastinal lymph nodes (Rulin Qian)
- Can Mediastinoscopic esophagectomy be a choice of curative surgery? - from the viewpoint of the characteristics of the short-term outcomes in thoracoscopic and mediastinoscopic esophagectomy (Xuewei Zhao)
- What is the indication of the mediastinoscopic esophagectomy, considered from the long-term outcomes? (Hitoshi Fujiwara)
- What is the indication of the mediastinoscopic esophagectomy, considered from the transition of the long-term outcomes? (Zheng Liang)
- What is the indication of the mediastinoscopic esophagectomy, considered from the dissected mediastinal lymph nodes and long-term outcomes? (Xinyu Ding)
- What is the indication of the mediastinoscopic esophagectomy, considered from the difference in the surgical site (mediastinal) recurrence between thoracoscopic and mediastinoscopic esophagectomy? (Tao Li)
Disclosure:
The special series “Mediastinoscopic Esophagectomy for Esophageal Cancer” was commissioned by the editorial office, Digestive Medicine Research without any funding or sponsorship. Yutaka Tokairin is serving as the unpaid Guest Editor for the special series.